Insight Molecular Diagnostics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 05/15/2026 | 11.93 M | $39.14 M | 4.57% | 39.15% |
| AWM INVESTMENT COMPANY, INC. | 05/15/2026 | 2.81 M | $9.20 M | -0.28% | 9.21% |
| PURA VIDA INVESTMENTS, LLC | 05/12/2026 | 947.13 K | $3.11 M | 0.00% | 3.11% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 840.78 K | $2.76 M | 100.00% | 2.76% |
| 05/15/2026 | 537.16 K | $1.76 M | 100.00% | 1.76% | |
| HEIGHTS CAPITAL MANAGEMENT, INC | 05/15/2026 | 392.55 K | $1.29 M | 100.00% | 1.29% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 262.05 K | $860.17 K | 13.46% | 0.86% |
| FNY INVESTMENT ADVISERS, LLC | 04/15/2026 | 247.42 K | $811.00 K | 509.65% | 0.81% |
| BLACKROCK, INC. | 05/13/2026 | 135.35 K | $443.93 K | 3.03% | 0.44% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 132.59 K | $434.90 K | 100.00% | 0.44% |
| FAMILY OFFICE RESEARCH LLC | 05/13/2026 | 127.27 K | $417.43 K | 100.00% | 0.42% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 103.47 K | $339.38 K | 68.58% | 0.34% |
| GHISALLO CAPITAL MANAGEMENT LLC | 05/15/2026 | 70.70 K | $231.88 K | 100.00% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 56.09 K | $183.99 K | -22.58% | 0.18% |
| STATE STREET CORP | 05/15/2026 | 50.75 K | $166.47 K | 6.28% | 0.17% |
| NORTHERN TRUST CORP | 05/14/2026 | 49.09 K | $161.02 K | 0.47% | 0.16% |
| MORGAN STANLEY | 05/15/2026 | 36.09 K | $118.37 K | 0.49% | 0.12% |
| XTX TOPCO LTD | 05/15/2026 | 30.35 K | $99.56 K | 100.00% | 0.10% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 29.00 K | $95.12 K | -62.44% | 0.10% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 25.23 K | $82.75 K | -11.01% | 0.08% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 24.14 K | $79.16 K | 0.00% | 0.08% |
| UBS GROUP AG | 05/05/2026 | 22.75 K | $74.62 K | 673.58% | 0.07% |
| ENGINEERS GATE MANAGER LP | 05/15/2026 | 18.25 K | $59.87 K | 100.00% | 0.06% |
| 04/29/2026 | 13.04 K | $42.79 K | 0.00% | 0.04% | |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 12.25 K | $40.18 K | 100.00% | 0.04% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 10.50 K | $34.44 K | -59.87% | 0.03% |
| PRIVATE ADVISOR GROUP, LLC | 04/27/2026 | 10.42 K | $34.16 K | 0.00% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 5.78 K | $18.94 K | 100.00% | 0.02% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 5.00 K | $16.40 K | 0.00% | 0.02% |
| ADVISORY SERVICES NETWORK, LLC | 05/15/2026 | 3.10 K | $10.17 K | 100.00% | 0.01% |
| CITIGROUP INC | 05/11/2026 | 815 | $2.67 K | 81,400.00% | 0.00% |
| GOLDEN STATE EQUITY PARTNERS | 04/28/2026 | 450 | $1.48 K | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 185 | $607 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 154 | $393 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 64 | $210 | 113.33% | 0.00% |
| PISCATAQUA SAVINGS BANK | 04/10/2026 | 25 | $81 | 0.00% | 0.00% |
| CASSADAY & CO WEALTH MANAGEMENT LLC | 05/07/2026 | 10 | $33 | 100.00% | 0.00% |
| ALBION FINANCIAL GROUP /UT | 04/27/2026 | 7 | $23 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 1 | $3 | 100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/07/2026 | 1 | $3 | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 1 | $3 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Insight Molecular Diagnostics Inc. institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Insight Molecular Diagnostics Inc.. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 11.93 M
AWM Investment Company, Inc.: 2.81 M
PURA VIDA INVESTMENTS, LLC: 947,134
Alyeska Investment Group, L.P.: 840,777
HEIGHTS CAPITAL MANAGEMENT, INC: 392,545
GEODE CAPITAL MANAGEMENT, LLC: 262,053
62.14% of Insight Molecular Diagnostics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.99 M shares in the last 24 months. This purchase volume represents approximately $102.53 M in transactions.